Longitudinal Fecal Shedding of SARS-CoV-2, Pepper Mild Mottle Virus, and Human Mitochondrial DNA in COVID-19 Patients liu2024longitudinal

The authors measured SARS-CoV-2, pepper mild mottle virus (PMMoV), and human mitochondrial DNA (mtDNA) in longitudinal stool samples collected from 42 COVID-19 patients for up to 42 days after the first sample collection date. Abundances were quantified using Digital PCR assays targeting the N1 genes. The symptom data (e.g., fever, cough, short of breath, diarrhea, headache, loss of smell, loss of taste, etc.) is currently not included in this data.

Analytes

stool_SARSCoV2_N1

SARS-CoV-2 RNA genome copy concentration in stool samples. The concentration were quantified in genome copies per dry weight of stool.

Biomarker: SARS-CoV-2
Specimen: stool
Units: gc/dry gram
Gene target: N1
Participants: 42
Negative samples: 115
Positive samples (not quantifiable): 0
Quantifiable samples: 40
Limit of quantification: 1000
Limit of detection: unknown

stool_PMMoV

PMMoV genome copy concentration in stool samples. The concentration were quantified in genome copies per dry weight of stool.

Biomarker: PMMoV
Specimen: stool
Units: gc/dry gram
Participants: 42
Negative samples: 1
Positive samples (not quantifiable): 0
Quantifiable samples: 154
Limit of quantification: unknown
Limit of detection: unknown

stool_mtDNA

mtDNA genome copy concentration in stool samples. The concentration were quantified in genome copies per dry weight of stool.

Biomarker: mtDNA
Specimen: stool
Units: gc/dry gram
Participants: 42
Negative samples: 0
Positive samples (not quantifiable): 0
Quantifiable samples: 155
Limit of quantification: unknown
Limit of detection: unknown